Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Sexually Transmitted Diseases Therapeutics Market Research Reports

Titlepublishedprice

Human Papillomavirus (HPV) - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... ajor markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Human Papillomavirus (HPV) forecasted market share for ten years to ......"
01-Sep-2016$4950

Genital Herpes - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Genital Herpes forecasted market share for ten years to 2023 segmented by seven ......"
01-Sep-2016$4950

Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... cross the globe. A key objective of the Genital Warts (Condylomata Acuminata) Report is to understand the market and pipeline status of the drugs around the Genital Warts (Condylomata Acuminata) to explore the generic development opportunities, licen......"
01-Sep-2016$2000

Chancroid-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... tive of the Chancroid Report is to understand the market and pipeline status of the drugs around the Chancroid to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategie......"
01-Sep-2016$2000

Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... objective of the Genital Herpes Report is to understand the market and pipeline status of the drugs around the Genital Herpes to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pip......"
01-Sep-2016$2000

Gonorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... tive of the Gonorrhea Report is to understand the market and pipeline status of the drugs around the Gonorrhea to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategie......"
01-Sep-2016$2000

Syphilis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ive of the Syphilis Report is to understand the market and pipeline status of the drugs around the Syphilis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. ......"
01-Sep-2016$2000

Chlamydia Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... A key objective of the Chlamydia Infections Report is to understand the market and pipeline status of the drugs around the Chlamydia Infections to explore the generic development opportunities, licensing opportunities and to gain competitive advantag......"
01-Sep-2016$2000

Genital Herpes - Pipeline Review, H2 2016

By Global Markets Direct
"...... drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press relea......"
10-Aug-2016$2000

Neisseria gonorrhoeae Infections - Pipeline Review, H2 2016

By Global Markets Direct
"...... tions, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research a......"
20-Jul-2016$2000